Get started
Author

Yasuto Otsubo

ORCID: 0009-0001-6359-7401
Observed ORCID: 0009-0001-6359-7401
OpenAlex ID: A5020853405
Mechanisms of substrate transport‐induced clustering of a glial glutamate transporter GLT‐1 in astroglial–neuronal cultures
2008 · Takayuki Nakagawa, Yasuto Otsubo, et al. · European Journal of Neuroscience · 49
Model‐Informed Drug Development: Steps Toward Harmonized Guidance
2023 · Scott Marshall, Malidi Ahamadi, et al. · Clinical Pharmacology & Therapeutics · 41
PDF
Similarities and Differences between US and Japan as to Pharmacogenomic Biomarker Information in Drug Labels
2011 · Yasuto Otsubo, Yasuko Asahina, et al. · Drug Metabolism and Pharmacokinetics · 29
Characterization of the Tritium-Labeled Analog of L-threo-β-Benzyloxyaspartate Binding to Glutamate Transporters
2006 · Keiko Shimamoto, Yasuto Otsubo, et al. · Molecular Pharmacology · 17
Regulatory Perspective on Remaining Challenges for Utilization of Pharmacogenomics-Guided Drug Developments
2013 · Yasuto Otsubo, Akihiro Ishiguro, et al. · Pharmacogenomics · 10
Use of Pharmacogenomics and Biomarkers in the Development of New Drugs for Alzheimer Disease in Japan⁎⁎The views expressed in this article are those of the author and do not necessarily reflect the official views of Ministry of Health, Labor, and Welfare, or the Pharmaceuticals Medical Devices Agency of Japan.
2015 · Yasuto Otsubo · Clinical Therapeutics · 9
How Clinical Pharmacology Can Support Clinical Trial Diversity and Inclusion
2025 · Michael Z. Liao, Aarti Sawant, et al. · Clinical and Translational Science · 3
PDF
Characteristics of Asian Participation in Multi-regional Clinical Trials Reviewed for Drug Approval in Japan: Opportunities for Collaboration Between South-East Asia, East Asia, and Japan
2023 · Yoko Aoi, Yuta Kato, et al. · Therapeutic Innovation & Regulatory Science · 3
PMDA initiatives to enhance drug development via multi-regional clinical trials
2024 · Yasuto Otsubo · Translational and Clinical Pharmacology · 2
PDF
Summary Report of a Public Workshop: Case Studies of Multi‐Regional Clinical Trial Incorporating Concept of the ICH E17 Guideline
2024 · Nobuko Matsushima, Yasuto Otsubo, et al. · Clinical Pharmacology & Therapeutics · 1
General Introduction of E17
2021 · Yoshiaki Uyama, Yasuto Otsubo, et al. · Chapman & Hall/CRC eBooks · 1
PGx/Biomarker Utilization for Regulatory Decision Making
2014 · Yu Sakamoto, Yasuto Otsubo, et al. · Elsevier eBooks · 1
Path to Regulatory Qualification Process Development
2013 · Yasuto Otsubo, Akihiro Ishiguro, et al. · Elsevier eBooks · 1
Implementation of the ICH E17 Guideline in Japan
2021 · Yoko Aoi, Shuji Kamada, et al. · Chapman & Hall/CRC eBooks
P4‐175: Development of a Guideline on the Clinical Evaluation of Drugs for Alzheimer's Disease in Japan (interim Report)
2014 · Keiju Motohashi, Takashi Moritoyo, et al. · Alzheimer s & Dementia
Regulatory Experience at the FDA, EMA, and PMDA
2013 · Akihiro Ishiguro, Yasuto Otsubo, et al. · Elsevier eBooks
Works count: 17
Citation count: 167
H-index: 6
I10-index: 5
Year
Topic
Type